brolucizumab ophthalmic

brolucizumab ophthalmic

[en Español]

brolucizumab ophthalmic

Pronunciation: BROE lue SIZ ue mab

Brand: Beovu

What is the most important information I should know about brolucizumab ophthalmic?

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What is brolucizumab ophthalmic?

Brolucizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with certain types of eye disorders, new blood vessels grow under the retina where they leak blood and fluid.

Brolucizumab ophthalmic (for the eyes) is used to treat the "wet form" of age-related macular degeneration.

Brolucizumab ophthalmic may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving brolucizumab ophthalmic?

You should not use brolucizumab if you are allergic to it, or if you have:

  • inflammation inside your eye; or
  • an infection in or around your eye.

Tell your doctor if you have ever had:

  • glaucoma;
  • cataracts; or
  • a stroke.

Do not use brolucizumab if you are pregnant. It could harm the unborn baby or cause birth defects. Use effective birth control to prevent pregnancy while you are receiving this medicine and for at least 1 month after your last dose.

Do not breastfeed while receiving this medicine, and for at least 1 month after your last dose.

How is brolucizumab ophthalmic given?

Brolucizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinic setting.

For a short time after your injection, your eyes will be checked periodically to make sure the injection has not caused any side effects.

Brolucizumab is usually given once per month for 3 months, and then once every 8 to 12 weeks.

Follow your doctor's dosing instructions very carefully. The timing of your monthly injections is very important for this medication to be effective.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your brolucizumab injection.

What happens if I overdose?

Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while receiving brolucizumab ophthalmic?

This medicine may cause blurred vision and may impair your reactions. Avoid driving or hazardous activity until you know how this medicine will affect you.

What are the possible side effects of brolucizumab ophthalmic?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • eye pain or redness, swelling around your eyes;
  • discharge or bleeding from the eye;
  • seeing "floaters" in your vision;
  • increased sensitivity to light;
  • decreased vision, tunnel vision, or seeing halos around lights; or
  • sudden numbness or weakness, problems with speech or balance.

Common side effects may include:

  • blurred vision, hazy vision;
  • increased sensitivity to light;
  • eye pain; or
  • seeing floaters.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect brolucizumab ophthalmic?

Medicine used in the eyes is not likely to be affected by other drugs you use. But many drugs can interact with each other. Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.

Where can I get more information?

Your pharmacist can provide more information about brolucizumab ophthalmic.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2020 Cerner Multum, Inc. Version: 1.01. Revision date: 10/24/2019.

Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by End-User License Agreement, which can be accessed by clicking on this link .